)
Visual
test
Immunic
Immunic (IMUX) investor relations material
Immunic Stifel 2026 Virtual CNS Forum summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Stifel 2026 Virtual CNS Forum summary18 Mar, 2026
2026 outlook and upcoming milestones
2026 is expected to be transformative, with phase III readouts for ENSURE-1 and ENSURE-2 studies in relapsing MS (RMS) anticipated at year-end.
Preparations for a New Drug Application (NDA) submission are underway, planned for the following year.
Vidofludimus calcium: Mechanism and differentiation
Designed as a safer, more selective DHODH inhibitor, avoiding kinase inhibition linked to side effects in similar drugs.
Acts as a potent Nurr1 activator, providing unique neuroprotective and anti-inflammatory effects.
Demonstrated a strong safety profile, with liver enzyme changes comparable to placebo and a short elimination half-life.
Safety and efficacy profile
Avoids key side effects of existing therapies, such as hepatotoxicity and embryo-fetal toxicity, due to its selectivity and pharmacokinetics.
Animal and clinical data suggest a differentiated safety profile, potentially reducing the need for certain safety warnings.
Clinical significance of Nurr1 activation
Compare vidofludimus calcium and Aubagio safety
Strategy for capturing CD20 switch patients
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Immunic
- Phase III MS trials for a novel dual-mechanism therapy near readout, targeting major market segments.IMUX
Leerink Global Healthcare Conference 202611 Mar 2026 - Vote on a reverse stock split to maintain Nasdaq listing and support capital access.IMUXProxy Filing2 Mar 2026
- $200M raised to fund phase 3 MS trials and commercial transition, with data expected by end 2026.IMUXQ4 202526 Feb 2026
- Shareholders will vote on a reverse stock split to maintain Nasdaq listing and support liquidity.IMUXProxy Filing20 Feb 2026
- Q2 net loss narrowed, cash at $79.7M, but liquidity concerns persist as trials advance.IMUXQ2 20242 Feb 2026
- Oral MS therapy shows dual neuroprotection and strong efficacy, with major trials underway.IMUX2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Q3 net loss was $24.4M; MS trials advanced, but liquidity concerns persist.IMUXQ3 202416 Jan 2026
- Pivotal MS trial readouts in 2025–2026 may establish a new best-in-class therapy.IMUXPiper Sandler 36th Annual Healthcare Conference11 Jan 2026
- Phase 2 and 3 MS trial readouts could unlock major value and reshape the treatment landscape.IMUXLeerink’s Global Healthcare Conference 202526 Dec 2025
Next Immunic earnings date
Q1 202614 May, 2026
Immunic
Next Immunic earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage